Clinical Trial Update: Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial [Phase 2]

View source ↗

Summary

A multicenter randomized Phase II trial is evaluating neoadjuvant atezolizumab and adjuvant atezolizumab plus bevacizumab with radiofrequency ablation for small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING